Financials

  • Market Capitalization 1.11 B
  • Employee 113
  • Founded 2017
  • CEO N/A
  • Website www.januxrx.com
  • Headquarter Delaware, United States
  • FIGI BBG00ZHSKH11
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-7.54
Rapporto prezzo/fatturato
85.51

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2315
LBRX
LB Pharmaceuticals Inc - Common Stock
36.00 USD-3.28%+3.99%-19.91%+130.92%1.16 B USD
2321
NBTX
Nanobiotix S.A. - ADSs
23.45 USD-0.97%-6.57%-34.86%-14.32%1.14 B USD
2384
SVRA
Savara, Inc. - Common Stock
4.84 USD-1.63%+1.26%-9.19%+43.62%994.43 M USD
2387
MNKD
MannKind Corporation - Common Stock
3.12 USD-5.17%-18.32%-17.02%-41.13%1.00 B USD

Notizie